The Latest News for Children with Cancer: Advancements in Research and Global Health Equity

Significant recent developments in pediatric cancer research include the collaboration between the Broad Institute, St. Jude’s Children’s Research Hospital, and Dana Farber Cancer Institute on the Pediatric Cancer Dependencies Accelerator project, aiming to identify vulnerabilities in pediatric tumors and develop new technologies for better therapies. Promising results have been observed in the treatment of refractory ALK-driven neuroblastoma with single-agent loralatinib and combination therapy. Furthermore, a large-scale Phase III clinical trial has helped optimize care for pediatric leukemia in resource-limited countries. The upcoming Coalition Against Childhood Cancer (CAC2) annual summit highlights the commitment of professionals in sharing important news and fostering collaboration in the childhood cancer community.

Source: Jennifer Ivanovich/Linkedin